Yuxian He

发表

Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design

Shibo Jiang, S. Heck, Shibo Jiang, 2006, Journal of Virology.

Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like Protease

Christian Drosten, Olaf Jahn, Elizabeth J. Soilleux, 2011, Journal of Virology.

Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.

Asim Kumar Debnath, Shibo Jiang, Nouri Neamati, 2005, Virology.

Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains

Shibo Jiang, Zhi Qi, Hong Lu, 2008, Proceedings of the National Academy of Sciences.

Measuring Recent Thymic Emigrants in Blood of Normal and HIV-1–Infected Individuals before and after Effective Therapy

Paul Palumbo, D. Ho, Steven Wolinsky, 1999, The Journal of experimental medicine.

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

Shibo Jiang, Wenhui Li, Shibo Jiang, 2004, Biochemical and Biophysical Research Communications.

Cross-Neutralization of Human and Palm Civet Severe Acute Respiratory Syndrome Coronaviruses by Antibodies Targeting the Receptor-Binding Domain of Spike Protein

Shibo Jiang, Wenhui Li, Shibo Jiang, 2006, The Journal of Immunology.

Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies

Shibo Jiang, Hong Lu, Shibo Jiang, 2005, The Journal of Immunology.

SARS vaccine development.

Shibo Jiang, Shibo Jiang, Shuwen Liu, 2005, Emerging infectious diseases.

Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model

Yan Guo, Guangyu Zhao, Shibo Jiang, 2006, Vaccine.

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines

Baoan Yang, Shibo Jiang, Qingyu Zhu, 2005, Virology.

Identification of Immunodominant Epitopes on the Membrane Protein of the Severe Acute Respiratory Syndrome-Associated Coronavirus

Shibo Jiang, Shibo Jiang, J. Niu, 2005, Journal of Clinical Microbiology.

Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response

Christian Drosten, Susanne Pfefferle, Elizabeth Soilleux, 2011, Journal of Virology.

A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity

Shibo Jiang, Shibo Jiang, Yuxian He, 2006, Biochemical and Biophysical Research Communications.

Vaccine design for severe acute respiratory syndrome coronavirus.

Shibo Jiang, Shibo Jiang, Yuxian He, 2005, Viral immunology.

Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccine

Shibo Jiang, Xuxia Yan, Shibo Jiang, 2006, Vaccine.